1. Generics Bulletin

Analysts Weigh Sandoz Prospects Ahead Of First Standalone Results

Jefferies Says Market Sees Post-Spinoff Sandoz As ‘A Show Me Money Story’

 
• By Dave Wallace

As industry onlookers await Sandoz’s first financial results as a standalone company, analysts have offered their initial impressions following the firm’s separation from former parent Novartis.

Businessman holding dollar banknotes with stock market graph and up arrow
Analysts are awaiting Sandoz’s upcoming Q3 results • Source: Shutterstock

With the newly-standalone Sandoz set to announce its first post-spinoff financial results on 24 October, analysts have been weighing the company’s prospects since its separation from former parent company Novartis earlier this month.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business